Melissa Lamirand, NP
Family · Durham, NCNPI 1346706371
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,750 of the $68,164 with a category attached, or 67.1%. Sanofi accounts for 98.1% of it on its own, with 6 other manufacturers making up the rest. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $587.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$67K
- GSK$748
- Karyopharm Therapeutics Inc.$220
- Acadia Pharmaceuticals Inc$111
- Janssen Scientific Affairs, LLC$90
- Y-mabs Therapeutics, Inc.$85
- plus $20 from 1 others
What the payments were for
- Consulting fees$7401%
- Speaking & faculty fees$45,75067%
- Travel & lodging$18,27227%
- Food & beverage$3,4025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 107 | $66,890 |
| GSK | 2 | $748 |
| Karyopharm Therapeutics Inc. | 2 | $220 |
| Acadia Pharmaceuticals Inc | 2 | $111 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Y-mabs Therapeutics, Inc. | 1 | $85 |
| Bristol Myers Squibb | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$68,164 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 94 | $84,153 |
| XareltoRivaroxaban | 17 | $13,617 |
| Acyclovir | 189 | $4,776 |
| CholestyramineCholestyramine (With Sugar) | 15 | $3,211 |
| ValacyclovirValacyclovir Hcl | 33 | $2,350 |
| Gabapentin | 88 | $1,972 |
| Potassium Chloride | 64 | $1,775 |
| Dexamethasone | 65 | $861 |
| Duloxetine Hcl | 39 | $838 |
| Pantoprazole Sodium | 76 | $834 |
| Omeprazole | 42 | $646 |
| Pregabalin | 14 | $589 |
| Famotidine | 25 | $438 |
| Klor-Con M20Potassium Chloride | 13 | $306 |
| Oxycodone Hcl | 23 | $303 |
Paid to pharmacies, not to this prescriber.
Other family in Durham
- Nicole RothmanDurham$268K
- Juanita PerkinsDurham$213K
- Amanda RidenhourDurham$13K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.